Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1239 Views
eMediNexus 14 February 2018
The US FDA has expanded the approval of the Impella line of heart pumps to include heart failure associated with cardiomyopathy leading to cardiogenic shock.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}